Benralizumab Patient Access Programme Study: Retrospective Study in UK Severe Asthma Centres
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
Study of AZD3152 Intramuscular Injection or Intravenous Infusion in Healthy Japanese Adult Participants
- Status
- COMPLETED
- Phase
- PHASE1
Combining Anti-PD-L1 Immune Checkpoint Inhibitor Durvalumab With TLR-3 Agonist Rintatolimod in Patients With Metastatic Pancreatic Ductal Adenocarcinoma for Therapy Efficacy
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Andexanet Alfa in Patients Requiring Urgent Surgery or Procedure
- Status
- WITHDRAWN
- Phase
- PHASE3
Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemotherapy (CT), Followed by Either Surgery and Adjuvant D or CRT and Consolidation D, in Resectable or Borderline Resectable Stage IIB-IIIB NSCLC (MDT-BRIDGE)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase 3b, Open-label, Multi-center Study on Durvalumab in Combination With Gemcitabine-based Chemotherapy as 1L Treatment for the Chinese Patients With Unresectable Biliary Tract Cancers (BTC)
- Status
- COMPLETED
- Phase
- PHASE3
Tezepelumab PRO Study
- Status
- COMPLETED
- Phase
- N/A
Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"
- Status
- RECRUITING
- Phase
- NA
A Phase I Study to Investigate the Effect of Hepatic Impairment on the PK, Safety, and Tolerability of AZD2693
- Status
- COMPLETED
- Phase
- PHASE1
National Register of Actionable Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Non-interventional Prospective Study of 1-st Line Treatment Approaches in OVArian Cancer Patients With HRD+ Status in Russian Federation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study on Determine the Utilisation and Clinical Outcomes of Evusheld in COVID-19 PrEP in China
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Tolerance of the Association of ANIFROLUMAB (300mg) IV Every Four Weeks and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo
- Status
- RECRUITING
- Phase
- PHASE2
Real-world, 52-week Prospective Study to Capture the Reasons for Switch to Triple Combination Therapy, Assess the Clinical and Patient Reported Outcomes in Adults With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Treated With Trixeo Aerosphere™ in Routine Care Settings in Greece
- Status
- COMPLETED
- Phase
- N/A
HER2-low Unresectable and/or Metastatic Breast Cancer in Russia
- Status
- COMPLETED
- Phase
- N/A
Abequolixron (RGX-104) and Durvalumab in Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
HER2(Human Epidermal Growth Factor Receptor 2) -Positive Metastatic Breast Cancer in Russia
- Status
- COMPLETED
- Phase
- N/A
Real-World Treatment Patterns and Patient Reported Outcome in COPD (REMIND)
- Status
- COMPLETED
- Phase
- N/A
MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2